Zevalin® Followed by Rituxan® Maintenance in Previously Treated Low Grade Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of a treatment regimen
using Zevalin® plus Rituxan® for patients who have low grade Non-Hodgkin's Lymphoma (NHL) or
relapsed Non-Hodgkin's lymphoma and have been previously treated. This study will use an
experimental scheduling regimen. No chemotherapy will be used in this study.